The Florida Institute for the Commercialization of Public Research, which bridges funding needs for in-state academically spawned companies, recently inked a funding agreement with Keystone Heights-based Auxadyne, whose technology was created at Florida State University.
Auxadyne, formed in 2015, is currently developing and marketing an innovative foam product called Xylafoam made of polyurethane and designed for use in medical and athletic equipment. The substance is mutable, able to self-adjust its shape to fit devices — socks worn by amputees to attach prosthetics, for example — or to endure pressure created by athletic movement during sports events.
"Conventional high impact resistance pads are hot, heavy, prone to cracking, shearing failures, and crease when bent causing pinch points," Auxadyne’s CEO Joe Condon said. "Our mission is to apply our auxetic foam technology to make comfort, protection and performance synonymous in the products we support."
The Florida Institute, based in Gainesville and Boca Raton, is a nonprofit entity acting as a liaison between Florida’s private research institutions and the state university system’s technology licensing and commercialization departments.
"Auxadyne's advanced foam technology is ideal for athletic wear and other applications," Dr. Jackson Streeter, the Institute’s CEO, said. "The material increases product safety and comfort without sacrificing other properties. We are pleased to support the Auxadyne team as they introduce Xylafoam to the commercial marketplace."
Want to get notified whenever we write about Florida Institute for the Commercialization of Public Research ?
Sign-up Next time we write about Florida Institute for the Commercialization of Public Research, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.